Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 533-540
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.533
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.533
Table 1 Diagnostic criteria for disseminated intravascular coagulation as defined by the Japanese Association for Acute Medicine
Score | |
Systemic inflammatory response syndrome criteria1 | |
≥ 3 | 1 |
0-2 | 0 |
Platelet count (× 103/L) | |
< 80 or > 50% decrease within 24 h | 3 |
≥ 80 and < 120; or > 30% decrease within 24 h | 1 |
≥ 120 | 0 |
Prothrombin time (Value of patient/Normal value) | |
≥ 1.2 | 1 |
< 1.2 | 0 |
Fibrin/fibrinogen degradation products (mg/L) | |
≥ 25 | 3 |
≥ 10 and < 25 | 1 |
< 10 | 0 |
Diagnosis | |
≥ 4 points | DIC |
Table 2 Comparison of patient characteristics between the recombinant human soluble thrombomodulin and control groups
rTM group(n = 30) | Control group (n = 36) | P value | |
Age (yr) | 77.0 ± 7.7 | 75.7 ± 9.4 | 0.554 |
Sex (Male/Female) | 22/8 | 21/15 | 0.203 |
Primary disease (Benign/Malignant) | 21/9 | 21/15 | 0.327 |
Severity of cholangitis (Severe/Moderate) | 28/2 | 32/4 | 0.845 |
DIC score | 5.4 ± 1.4 | 5.2 ± 1.2 | 0.523 |
SIRS score | 2.4 ± 1.3 | 2.6 ± 1.0 | 0.599 |
Biliary drainage | 25 | 24 | 0.123 |
Anticoagulant drug | |||
AT | 26 | 16 | < 0.001 |
GM | 14 | 30 | 0.002 |
NM | 4 | 18 | 0.004 |
DS | 0 | 6 | 0.019 |
Antibiotics | |||
MEPM | 19 | 14 | 0.048 |
IPM/CS | 0 | 7 | 0.031 |
DRPM | 5 | 0 | 0.037 |
SBT/CPZ | 5 | 14 | 0.047 |
TAZ/PIPC | 1 | 1 | 0.556 |
Table 3 Factors associated with persistent disseminated intravascular coagulation (univariate analysis)
Persistent DIC (n = 25) | Resolved DIC (n = 41) | P value | OR (95%CI) | |
Age (> 80 yr) | 9 | 18 | 0.610 | 0.72 (0.26-2.0) |
Female | 7 | 16 | 0.431 | 0. 61 (0.21-1.8) |
Primary disease (Malignant) | 15 | 9 | 0.003 | 5.3 (1.8-16) |
Severity of cholangitis (Severe) | 23 | 37 | 1.000 | 1.2 (0.21-7.3) |
DIC score (> 6) | 12 | 15 | 0.442 | 1.6 (0.58-4.4) |
SIRS score (> 3) | 11 | 24 | 0.313 | 0.56 (0.20-1.5) |
Without biliary drainage | 14 | 3 | < 0.001 | 16 (3.9-66) |
Without rTM | 19 | 17 | 0.010 | 4.5 (1.5-14) |
Without AT | 12 | 13 | 0.203 | 2.0 (0.71-5.5) |
Without GM | 5 | 17 | 0.107 | 0.35 (0.11-1.1) |
Without NM | 12 | 32 | 0.016 | 0.26 (0.088-0.76) |
Without DS | 22 | 37 | 1.000 | 0.79 (0.16-3.9) |
Plt (< 80 × 103/μL) | 12 | 24 | 0.452 | 0.65 (0.24-1.8) |
FDP (> 25 μg/mL) | 17 | 20 | 0.201 | 2.2 (0.79-6.3) |
PT-INR | 10 | 12 | 0.426 | 1.6 (0.57-4.6) |
Fib (< 200 mg/dL) | 7 | 5 | 0.186 | 2.8 (0.78-10) |
CRP (> 15 mg/dL) | 7 | 14 | 0.786 | 0.75 (0.25-2.2) |
T-Bil (> 10 mg/dL) | 4 | 3 | 0.412 | 0.49 (0.35-12) |
Table 4 Factors associated with persistent disseminated intravascular coagulation (multivariate analysis)
P value | OR (95%CI) | |
Primary disease (Malignant) | 0.055 | 3.9 (0.97-16) |
Without biliary drainage | 0.003 | 12 (2.3-60) |
Without rTM | 0.080 | 4.3 (0.84-22) |
Without GM | 0.680 | 1.5 (0.25-8.5) |
Without NM | 0.188 | 0.37 (0.083-1.6) |
Fib (< 200 mg/dL) | 0.403 | 2.2 (0.35-14) |
- Citation: Suetani K, Okuse C, Nakahara K, Michikawa Y, Noguchi Y, Suzuki M, Morita R, Sato N, Kato M, Itoh F. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. World J Gastroenterol 2015; 21(2): 533-540
- URL: https://www.wjgnet.com/1007-9327/full/v21/i2/533.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.533